Z3U-77101-78630
2 vaccinations
1 coded response
23 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 940 / CA
- Registered
- 2022-10-30
- Relationship
- Child or adolescent in my care
- Guardian
- 7ZZ-19699-34246
- Race
- N/A
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-10-29
Dose 1 — Moderna
-
2022-10-30
Registered in v-safe
- 2022-10-30
- 2022-10-31
- 2022-11-01
- 2022-11-02
- 2022-11-03
- 2022-11-04
- 2022-11-05
- 2022-11-12
-
2022-11-19
Survey response — 21 day, dose 1, under 3MedDRA: Respiratory syncytial virus infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
- 2022-11-26
-
2022-12-03
Dose 2 — Moderna
- 2022-12-03
- 2022-12-04
- 2022-12-06
- 2022-12-08
- 2022-12-09
- 2022-12-10
- 2022-12-17
- 2022-12-24
- 2022-12-31
- 2023-01-07
- 2023-01-14
- 2023-03-04
- 2023-06-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-10-29 | Moderna | No |
| 2 | 2022-12-03 | Moderna | No |
Free text
Release 12 (Under 3)
Symptoms: RSV infection
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Respiratory syncytial virus infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release